SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-045836
Filing Date
2021-02-17
Accepted
2021-02-17 08:04:28
Documents
3
Period of Report
2021-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d143096d8k.htm 8-K 19396
2 EX-99.1 d143096dex991.htm EX-99.1 12112
3 GRAPHIC g143096g49l31.jpg GRAPHIC 3070
  Complete submission text file 0001193125-21-045836.txt   37124
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 21642691
SIC: 2834 Pharmaceutical Preparations